Daniel Kirouac, Ph.D.

Vice President of Translational and Systems Pharmacology (TSP)

Dan brings over a decade of experience spanning academia, small biotech, big pharma, and consulting roles. Dan’s expertise includes computational modeling and translational science. His career highlights include spearheading the establishment of scientific teams, developing novel computational methods, and integrating advanced technologies into the research and development pipeline. Dan is extensively engaged in the wider scientific community. He has co-authored 27 publications and actively participated in over 30 scientific symposia worldwide, focusing on systems pharmacology, bioinformatics, and cancer therapy. Additionally, he holds an adjunct professorship at the University of British Columbia and serves on leadership committees at the University of Florida and the American Society for Clinical Pharmacology.



Recent publications by this scientist

Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics

March 19, 2024

Engineered T cells, particularly CAR T cells, have revolutionized hematological cancer treatment. However, their complexity poses challenges. This research explores how mathematical models, utilizing clinical data, can elucidate relationships between product characteristics, patient physiology, and clinical outcomes, thereby facilitating the development of next-generation cell therapies.

Read Article